Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 23302512)

1.

ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury.

van Rijt WG, Nieuwenhuijs-Moeke GJ, van Goor H, Jespersen B, Ottens PJ, Ploeg RJ, Leuvenink HG.

J Transl Med. 2013 Jan 9;11:9. doi: 10.1186/1479-5876-11-9.

2.

Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injury.

van Rijt WG, Nieuwenhuijs-Moeke GJ, van Goor H, Ottens PJ, Ploeg RJ, Leuvenink HG.

J Transl Med. 2013 Nov 13;11:286. doi: 10.1186/1479-5876-11-286.

3.

Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.

van Rijt WG, van Goor H, Ploeg RJ, Leuvenink HG.

Transpl Int. 2014 Mar;27(3):241-8. doi: 10.1111/tri.12174. Epub 2013 Aug 22. Review.

PMID:
23964738
4.

Beware the low HDAC11: males at risk for ischemic kidney injury.

Mrug M, Sanders PW.

Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F973-4. doi: 10.1152/ajprenal.00308.2013. Epub 2013 Jul 24. No abstract available.

5.

Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin.

Hussein AA, Barakat N, Awadalla A, Shokeir AA.

Can J Physiol Pharmacol. 2012 Nov;90(11):1535-43. doi: 10.1139/y2012-120. Epub 2012 Nov 8.

PMID:
23181281
6.

Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction.

Zhu JX, Kalbfleisch M, Yang YX, Bihari R, Lobb I, Davison M, Mok A, Cepinskas G, Lawendy AR, Sener A.

BJU Int. 2012 Dec;110(11 Pt C):E1218-27. doi: 10.1111/j.1464-410X.2012.11555.x. Epub 2012 Oct 9.

PMID:
23046222
7.

Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats.

Fouad AA, Al-Mulhim AS, Jresat I.

Life Sci. 2012 Sep 17;91(7-8):284-92. doi: 10.1016/j.lfs.2012.07.030. Epub 2012 Aug 1.

PMID:
22877651
8.

Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.

Jiang S, Tang Q, Rong R, Tang L, Xu M, Lu J, Jia Y, Ooi Y, Hou J, Guo J, Yang B, Zhu T.

Eur J Pharmacol. 2012 Aug 5;688(1-3):56-61. doi: 10.1016/j.ejphar.2012.05.001. Epub 2012 May 16.

PMID:
22609232
9.

Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.

Grossini E, Molinari C, Pollesello P, Bellomo G, Valente G, Mary D, Vacca G, Caimmi P.

J Pharmacol Exp Ther. 2012 Aug;342(2):376-88. doi: 10.1124/jpet.112.193961. Epub 2012 May 7.

10.

Protective effect of 17β-estradiol on ischemic acute kidney injury through the renal sympathetic nervous system.

Tanaka R, Tsutsui H, Kobuchi S, Sugiura T, Yamagata M, Ohkita M, Takaoka M, Yukimura T, Matsumura Y.

Eur J Pharmacol. 2012 May 15;683(1-3):270-5. doi: 10.1016/j.ejphar.2012.02.044. Epub 2012 Mar 8.

PMID:
22426161
11.

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Patel NS, Kerr-Peterson HL, Brines M, Collino M, Rogazzo M, Fantozzi R, Wood EG, Johnson FL, Yaqoob MM, Cerami A, Thiemermann C.

Mol Med. 2012 May 9;18:719-27. doi: 10.2119/molmed.2012.00093.

12.

Protective effects of acute lithium preconditioning against renal ischemia/reperfusion injury in rat: role of nitric oxide and cyclooxygenase systems.

Talab SS, Elmi A, Emami H, Nezami BG, Assa S, Ghasemi M, Tavangar SM, Dehpour AR.

Eur J Pharmacol. 2012 Apr 15;681(1-3):94-9. doi: 10.1016/j.ejphar.2012.01.042. Epub 2012 Feb 9.

PMID:
22342279
13.

Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.

Caetano AM, Vianna Filho PT, Castiglia YM, Golim MA, de Souza AV, de Carvalho LR, Deffune E, de Oliveira C, Vianna PT.

Transplant Proc. 2011 Dec;43(10):3618-21. doi: 10.1016/j.transproceed.2011.10.049.

14.

Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.

Hu L, Yang C, Zhao T, Xu M, Tang Q, Yang B, Rong R, Zhu T.

J Surg Res. 2012 Jul;176(1):260-6. doi: 10.1016/j.jss.2011.06.035. Epub 2011 Jul 19.

PMID:
21816412
15.

Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.

Efrati S, Berman S, Hamad RA, Siman-Tov Y, Ilgiyaev E, Maslyakov I, Weissgarten J.

Nephrol Dial Transplant. 2012 Jan;27(1):136-45. doi: 10.1093/ndt/gfr256. Epub 2011 Jun 16.

16.

A biphasic response to nitric oxide donation in an ex vivo model of donation after cardiac death renal transplantation.

Yates PJ, Hosgood SA, Nicholson ML.

J Surg Res. 2012 Jun 15;175(2):316-21. doi: 10.1016/j.jss.2011.03.073. Epub 2011 Apr 24.

PMID:
21592523
17.

Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats.

Esposito E, Mondello S, Di Paola R, Mazzon E, Italiano D, Paterniti I, Mondello P, Aloisi C, Cuzzocrea S.

Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):493-508. doi: 10.1007/s00210-011-0610-5. Epub 2011 Mar 11.

PMID:
21394482
18.

Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.

Sølling C, Christensen AT, Krag S, Frøkiaer J, Wogensen L, Krog J, Tønnesen EK.

Acta Anaesthesiol Scand. 2011 Feb;55(2):185-95. doi: 10.1111/j.1399-6576.2010.02369.x.

PMID:
21226860
19.

Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model.

Ishii Y, Sawada T, Murakami T, Sakuraoka Y, Shiraki T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S.

Nephrol Dial Transplant. 2011 Apr;26(4):1157-62. doi: 10.1093/ndt/gfq601. Epub 2010 Oct 8.

20.

Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury.

Simon F, Scheuerle A, Gröger M, Stahl B, Wachter U, Vogt J, Speit G, Hauser B, Möller P, Calzia E, Szabó C, Schelzig H, Georgieff M, Radermacher P, Wagner F.

Shock. 2011 Feb;35(2):156-63. doi: 10.1097/SHK.0b013e3181f0dc91.

PMID:
20661185
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk